Etoposide (Accord Healthcare Inc.)


Welcome to the PulseAid listing for the Etoposide drug offered from Accord Healthcare Inc.. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Accord Healthcare Inc.
NON-PROPRIETARY NAME: Etoposide
SUBSTANCE NAME: ETOPOSIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2015-03-03
END MARKETING DATE: 0000-00-00


Etoposide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEtoposide from Accord Healthcare Inc.
LABELER NAME: Accord Healthcare Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 2015-03-03
END MARKETING DATE: 0000-00-00
PRODUCT ID: 16729-114_5b5fb93c-86f2-b007-e053-2991aa0ad683
PRODUCT NDC: 16729-114
APPLICATION NUMBER: ANDA074513

Other ETOPOSIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Etoposide
BluePoint LaboratoriesEtoposide
Fresenius Kabi USA, LLCEtoposide
Mylan Pharmaceuticals Inc.Etoposide
Teva Parenteral Medicines, Inc.Toposar
ThyMoorgan GmbH Pharmazir & Co. K.GEtoposide
West-Ward Pharmaceuticals CorpEtoposide